Thyrocare Technologies Ltd Share Price

Overview

Thyrocare Technologies Ltd share price is currently ₹604.00, down by - ₹6.04 (0.99%) from its previous closing price of ₹610.04. The share price has gained 9.69% over the past month and gained 37.01% over the past year. The stock's 52-week low and high are ₹0.00 and ₹656.92, respectively. Thyrocare Technologies Ltd has a market capitalisation of ₹ 9,930.00 Cr. The share price was last updated on 18 Aug 2026, 03:55 PM IST.

Thyrocare Technologies Ltd

THYROCARE

₹0.00

- ₹6.04

0.99%

Healthcare

₹0.00(%)1D

Updated: 18 Aug 2026, 03:55:43 pm IST

Market Data

Open Price

₹615.50

Prev. Close

₹610.04

₹598.76

Day Low

₹618.93

Day High

₹0.00

52 Week Low

₹656.92

52 Week High

HealthcareHospital & Healthcare Services

CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

54.51

Sector PE

42.16

PB Ratio

16.61

Sector PB

5.83

EPS

11.08

Dividend Yield

4.00

Today's Volume

280.431 K

5 Day Avg. Volume

1.917 M

PEG Ratio

-1.36

Market Cap.

₹ 9,930.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 70% at ₹7/Share	23-Jun-2026	23-Jun-2026
Bonus2:1	28-Nov-2025	28-Nov-2025
DividendsInterim Dividend of 70% at ₹7/Share	24-Oct-2025	24-Oct-2025
DividendsFinal Dividend of 210% at ₹21/Share	25-Jul-2025	25-Jul-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Nippon India Small Cap Fund - Growth	51.68 Lac	51.68 Lac no change
HSBC Midcap Fund - Regular Plan - Growth	43.73 Lac	43.73 Lac no change
Nippon India Pharma Fund - Growth	43.67 Lac	40.17 Lac (8.02%)
Aditya Birla Sun Life ELSS Tax Saver Fund - IDCW	33.49 Lac	33.49 Lac no change
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth	26.98 Lac	22.87 Lac (15.27%)

Show all holdings

About Thyrocare Technologies Ltd 👋

Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It offers a range of diagnostic and related healthcare tests and services that are focused on early detection, preventive care, and ongoing disease monitoring. Its segments include diagnostic testing services, Imaging Services, and others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services include diagnostic and imaging services, the selling of radiopharmaceuticals, and consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and the selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, and a medical cyclotron facility across India. It is also focused on offering pathological services.